Prostate Cancer
Innovative Medicines Initiative Launches Project to Develop Real-World Oncology Data Platform
Collaborators will collect data within the platform, analyze it using machine learning, and glean insights for personalizing prostate, breast, and lung cancer treatment.
Caris Life Sciences, Essa Pharma Ink Liquid Biopsy Partnership for Prostate Cancer Trial
Essa will use Caris' blood-based sequencing tests to assess the genetic profiles of mCRPC patients enrolled in a Phase I trial of the firm's investigational agent.
Novartis' Advanced Accelerator Applications Licenses Theragnostics' Gallium-68 Platform
The Novartis subsidiary licensed Theragnostics' Gallium-68 platform to support its growing pipeline of radiopharmaceutical products.
Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows
The researchers said the approach could be a short-term measure while genetic studies of more diverse ancestral populations are performed.
Convergent Therapeutics, Point Biopharma Pair Antibody, Radioligand Therapy in Prostate Cancer Study
The companies will enroll up to 33 PSMA-positive, advanced castration-resistant prostate cancer patients in a Phase I/II study of CONV 01-alpha and PNT2002.